Tag: APS

Pain Expert to Discuss Osteoarthritis Trials at APS 2018

DURHAM, N.C., MARCH 2, 2018 — You know that well-worn advice about picking investments: that past performance doesn’t guarantee future results. The same can be said of selecting clinical trial sites, as Premier Research’s top analgesia expert will explore at the American Pain Society’s 2018 Scientific Summit on March 6 in Anaheim. Michael Kuss, Vice...

Clinical Research: Phase 1 - Phase 4

Six Insights To Treating Fibromyalgia

The journey to treating fibromyalgia has taken a sometimes circuitous path. After a burst of activity about a decade ago, the pursuit of new therapies took a years-long pause before reigniting in recent years. In the past five years, we’ve performed 16 fibromyalgia clinical trials (more than any other CRO), and here are some reflections...

Consulting

Rushing Site Selection in Fibromyalgia Trials, Not a Great Idea

In the early days of fibromyalgia drug research, trial site selection centered almost exclusively on rheumatologists and pain centers. But with more drugs on the market and still more studies underway, there has been significant expansion in the number of sites equipped to conduct this research. Up to a point, anyway. As fibromyalgia therapy matures,...

Clinical Research: Phase 1 - Phase 4

In Treating Fibromyalgia, Goal Is Overall Benefit — Not Just Less Pain

The most prevalent gauge of efficacy in the study of fibromyalgia drugs is — no surprise here — pain relief. But analgesic effect alone is not a sufficient measure in the eyes of the FDA, which seeks evidence of overall benefit and improvement in patient function when evaluating treatments for a condition commonly associated with...

Consulting

Premier Research Expert to Discuss Fibromyalgia at Pain Society Meeting

DURHAM, N.C., May 17, 2017 — Scott Millard, Premier Research’s head of analgesia strategic development, will speak on fibromyalgia clinical trials during a Town Hall Talk at the American Pain Society’s Annual Scientific Meeting, May 17-20 in Pittsburgh. Mr. Millard will present Operationalizing Clinical Trials in Fibromyalgia on Thursday, May 18, starting at 9:40 a.m....